Cancer

Items 151-160 of 370

per page
Set Descending Direction
  1. DcR3 (human):Fc (human) (rec.)
    CHI-HF-210DcR3
    CHI-HF-210DcR3-C100100 µg
    CHF 460.00
  2. DDX3 (human) (rec.) (active) (1000µg)
    BBL-2253
    BBL-2253-M0011 mg
    CHF 6'041.00
    DDX3 (human) (rec.) (active) (1000µg)
  3. DDX3 (human) (rec.) (active) (100µg)
    BBL-2252
    BBL-2252-C100100 µg
    CHF 1'809.00
    DDX3 (human) (rec.) (active) (100µg)
  4. DDX3 (human) (rec.) (active) (10µg)
    BBL-2251
    BBL-2251-C01010 µg
    CHF 600.00
    DDX3 (human) (rec.) (active) (10µg)
  5. DLK1 (human) (rec.)
    AG-40A-0133
    AG-40A-0133-C01010 µg
    CHF 290.00
  6. DLK1 (human):Fc (human) (rec.)
    AG-40B-0152
    AG-40B-0152-C01010 µg
    CHF 290.00
    Replaces AG-40A-0118
  7. DLK1 (mouse):Fc (human) (rec.)
    AG-40A-0107Y
    AG-40A-0107Y-C01010 µg
    CHF 290.00
    AG-40A-0107Y-30103 x 10 µg
    CHF 575.00
    Replaces AG-40A-0107
    DLK1 (mouse):Fc (human) (rec.)
  8. DLK2 (human):Fc (human) (rec.)
    AG-40A-0158
    AG-40A-0158-C01010 µg
    CHF 290.00
    AG-40A-0158-C05050 µg
    CHF 830.00
  9. DLL1 (human) (rec.)
    AG-40A-0073
    AG-40A-0073-C01010 µg
    CHF 190.00
    AG-40A-0073-C05050 µg
    CHF 380.00
    Adipogenesis inhibition of MSCs.
MSCs (Mesenchymal stem cells) were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin and glutamine. For differentiation of MSCs, MSCs were cultured in adipogenic medium which was gr
  10. DLL1 (human):Fc (human) (rec.)
    AG-40A-0116Y
    AG-40A-0116Y-C01010 µg
    CHF 305.00
    AG-40A-0116Y-C05050 µg
    CHF 835.00
    Adipogenesis inhibition of 3T3L1 cells.3T3L1 cells were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin. Adipogenesis was initiated by adding 1μM dexamethasone, 0.5mM IBMX, 10μg/ml insulin (day 0) until day

Items 151-160 of 370

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.